BAJAJ BROKING

Notification
No new Notification messages
Wagons Learning IPO is Open!
Apply for the Wagons Learning IPO through UPI in just minutes.
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.

22806

211179

ZENITHDRUG

img img img img
No Data Available

Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

ZENITH DRUGS LIMITED performance

Today’s low

Today’s high

₹ 78.00 ₹ 81.35
₹ 79.50

52 week low

52 week high

₹ 47.15 ₹ 154.40
₹ 79.50

Open Price

₹ 78.05

Prev. Close

₹ 81.35

Volume (Shares)

4800.00

Total traded value

₹ 3.81

Upper Circuit

₹ 85.40

Lower Circuit

₹ 77.30

info

ZENITH DRUGS LIMITED Share Price Update

As of the latest trading session, ZENITH DRUGS LIMITED share price is currently at ₹ 79.5, which is down by ₹ -1.84 from its previous closing. Today, the stock has fluctuated between ₹ 78.00 and ₹ 81.35. Over the past year, ZENITH DRUGS LIMITED has achieved a return of 24.02 %. In the last month alone, the return has been -7.55 %. Read More...

ZENITH DRUGS LIMITED fundamentals


  • Market cap (Cr)

    136.33

  • P/E Ratio (TTM)

    14.30

  • Beta

    0.83

  • Book Value / share

    36.28

  • Return on equity

    26.44%

  • EPS (TTM)

    6.16

  • Dividend yield

    0.63%

  • Net profit/quarter (Cr)

    0.00

info icon alternate text
  • Market cap (Cr)

    0.0

  • P/E Ratio (TTM)

    0.0

  • Beta

    0.0

  • Book Value / share

    0.0

  • Return on equity

    0.0%

  • EPS (TTM)

    0.0

  • Dividend yield

    0.63%

  • Net profit/quarter (Cr)

    0.0

info icon alternate text

ZENITH DRUGS LIMITED Financials

  • Key Results

  • Key Ratios

  • Balance sheet

  • Cash Flow

  • Competition

info-icon

Revenue

Net income

Particulars MAR 2024 (Values in Cr)
Revenue 131.62
Operating Expense 119.00
Net Profit 9.54
Net Profit Margin (%) 7.24
Earnings Per Share (EPS) 5.56
EBITDA 19.04
Effective Tax Rate (%) 25.50
Particulars MAR 2023 (Values in Cr)
Revenue 114.52
Operating Expense 109.10
Net Profit 4.88
Net Profit Margin (%) 4.26
Earnings Per Share (EPS) 122.03
EBITDA 10.29
Effective Tax Rate (%) 26.72
Particulars MAR 2022 (Values in Cr)
Revenue 91.66
Operating Expense 88.21
Net Profit 3.21
Net Profit Margin (%) 3.50
Earnings Per Share (EPS) 80.32
EBITDA 7.88
Effective Tax Rate (%) 27.04
Particulars MAR 2021 (Values in Cr)
Revenue 73.40
Operating Expense 68.91
Net Profit 3.07
Net Profit Margin (%) 4.18
Earnings Per Share (EPS) 76.66
EBITDA 7.31
Effective Tax Rate (%) 33.26
Particulars MAR 2020 (Values in Cr)
Revenue 77.52
Operating Expense 73.46
Net Profit 3.40
Net Profit Margin (%) 4.38
Earnings Per Share (EPS) 85.00
EBITDA 7.10
Effective Tax Rate (%) 30.32
Particulars MAR 2024 (Values in Cr)
Book Value / Share 36.31
ROE % 24.13
ROCE % 25.16
Total Debt to Total Equity 0.63
EBITDA Margin 12.13
Particulars MAR 2023 (Values in Cr)
Book Value / Share 443.04
ROE % 32.74
ROCE % 24.04
Total Debt to Total Equity 1.51
EBITDA Margin 8.03
Particulars MAR 2022 (Values in Cr)
Book Value / Share 302.27
ROE % 25.89
ROCE % 21.47
Total Debt to Total Equity 1.56
EBITDA Margin 8.70
Particulars MAR 2024 (Values in Cr)
Book Value / Share 36.28
ROE % 26.44
ROCE % 27.46
Total Debt to Total Equity 0.62
EBITDA Margin 14.47
Particulars MAR 2023 (Values in Cr)
Book Value / Share 443.30
ROE % 31.92
ROCE % 24.70
Total Debt to Total Equity 1.38
EBITDA Margin 8.99
Particulars MAR 2022 (Values in Cr)
Book Value / Share 321.27
ROE % 28.55
ROCE % 23.89
Total Debt to Total Equity 1.43
EBITDA Margin 7.75
Particulars MAR 2021 (Values in Cr)
Book Value / Share 240.95
ROE % 37.88
ROCE % 27.83
Total Debt to Total Equity 1.70
EBITDA Margin 9.01
Particulars MAR 2020 (Values in Cr)
Book Value / Share 164.29
ROE % 51.75
ROCE % 33.21
Total Debt to Total Equity 1.84
EBITDA Margin 8.27
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 8.80
Total Assets 135.03
Total Liabilities 135.03
Total Equity 62.33
Share Outstanding 17148800
Price to Book Ratio 1.73
Return on Assets (%) 7.10
Return on Capital (%) 11.03
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 0.27
Total Assets 97.92
Total Liabilities 97.92
Total Equity 17.73
Share Outstanding 400000
Price to Book Ratio 0.00
Return on Assets (%) 4.98
Return on Capital (%) 11.13
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 3.00
Total Assets 68.58
Total Liabilities 68.58
Total Equity 12.10
Share Outstanding 400000
Price to Book Ratio 0.00
Return on Assets (%) 4.57
Return on Capital (%) 10.15
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 8.74
Total Assets 134.17
Total Liabilities 134.17
Total Equity 62.21
Share Outstanding 17148800
Price to Book Ratio 1.73
Return on Assets (%) 7.10
Return on Capital (%) 11.07
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 0.19
Total Assets 97.22
Total Liabilities 97.22
Total Equity 17.73
Share Outstanding 400000
Price to Book Ratio 0.00
Return on Assets (%) 5.02
Return on Capital (%) 11.31
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 2.88
Total Assets 66.18
Total Liabilities 66.18
Total Equity 12.85
Share Outstanding 400000
Price to Book Ratio 0.00
Return on Assets (%) 4.85
Return on Capital (%) 10.84
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 1.84
Total Assets 46.54
Total Liabilities 46.54
Total Equity 9.63
Share Outstanding 400000
Price to Book Ratio 0.00
Return on Assets (%) 6.58
Return on Capital (%) 12.21
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 0.43
Total Assets 43.72
Total Liabilities 43.72
Total Equity 6.57
Share Outstanding 400000
Price to Book Ratio 0.00
Return on Assets (%) 7.77
Return on Capital (%) 22.9
Particulars MAR 2024 (Values in Cr)
Net Income 13.44
Cash from Operations -8.97
Cash from Investing 26.00
Cash from Financing -4.47
Net change in Cash 8.52
Free Cash Flow -3.64
Particulars MAR 2023 (Values in Cr)
Net Income 6.65
Cash from Operations -2.94
Cash from Investing -0.26
Cash from Financing 4.99
Net change in Cash -0.04
Free Cash Flow 2.62
Particulars MAR 2022 (Values in Cr)
Net Income 4.40
Cash from Operations 6.47
Cash from Investing -5.24
Cash from Financing 1.24
Net change in Cash 1.15
Free Cash Flow 9.05
Particulars MAR 2024 (Values in Cr)
Net Income 13.29
Cash from Operations -8.49
Cash from Investing 25.51
Cash from Financing -4.48
Net change in Cash 8.54
Free Cash Flow -3.16
Particulars MAR 2023 (Values in Cr)
Net Income 6.65
Cash from Operations -2.44
Cash from Investing -2.04
Cash from Financing 6.30
Net change in Cash -0.01
Free Cash Flow -0.76
Particulars MAR 2022 (Values in Cr)
Net Income 4.40
Cash from Operations 6.15
Cash from Investing -3.04
Cash from Financing -0.82
Net change in Cash 1.04
Free Cash Flow 8.72
Particulars MAR 2021 (Values in Cr)
Net Income 4.60
Cash from Operations 0.47
Cash from Investing -1.42
Cash from Financing 2.88
Net change in Cash 0.56
Free Cash Flow 1.90
Particulars MAR 2020 (Values in Cr)
Net Income 4.87
Cash from Operations 4.99
Cash from Investing -4.93
Cash from Financing 1.35
Net change in Cash -0.09
Free Cash Flow 9.92
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 36.46 19.60 1.99 279.41 34.11 / 77.70
BLISS GVS PHARMA LTD 119.00 15.60 1.24 1253.91 92.25 / 184.95
CIPLA LTD 1549.65 25.08 4.41 125155.99 1310.05 / 1702.00
FERMENTA BIOTECH LIMITED 260.70 21.60 2.64 767.27 145.00 / 449.00
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 36.46 21.96 6.19 279.41 34.11 / 77.70
AMRUTAJAN HEALTH LTD 692.80 40.61 6.72 2002.93 548.05 / 861.40
ASTRAZENECA PHARMA IND LT 8665.50 129.24 31.88 21663.75 5000.00 / 9199.00
BLISS GVS PHARMA LTD 119.00 15.45 1.22 1253.91 92.25 / 184.95

ZENITH DRUGS LIMITED Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
79.50 -2.27 redarrow
red-green-graph indicator
13 Bearish
3 Bullish
  • 5 Days 81.10
  • 26 Days 80.40
  • 10 Days 82.60
  • 50 Days 78.70
  • 12 Days 82.70
  • 100 Days 81.20
  • 20 Days 81.60
  • 200 Days 81.50
80.03 PIVOT

First Support

78.32

First Resistance

83.07

Second Support

75.28

Second Resistance

84.78

Third Support

73.57

Third Resistance

87.82

RSI

49.11

ADX

37.00

MACD

2.27

Williams % R

-86.11

Commodity Channel Index (CCI)

-83.23

Date

2025-04-30

Week

12667.00

Same Day

4800.00

Month

51326.00

1 Year

0.84

3 Year

0.91

Over 1 Month

-7.55%

down

Over 1 Year

24.02%

down

Over 3 Months

2.31%

down

Over 3 Years

0.00%

down

Over 6 Months

-19.53%

down

Over 5 Years

0.00%

down

Invest with Confidence

Left Arrow
MTF boost
Buy Now. Pay Later

Boost your capital upto 5 X

img
IPO boost
Invest in IPOs
They give good returns
img
Right Arrow

ZENITH DRUGS LIMITED shareholding pattern

  • Shareholding Summary

  • Historical Promotor Holding

  • Historical MF Holding

  • Historical FII Holding

Holding

Others
29.6%
Promoter Holdings
69.97%
FII
0.41%
DII
0.0%
Promoter Shares(Pledge Percentage)
0.0%
Name Shares Category
Ajay Singh Dassundi 3861990.0 (22.52%) Shareholding of Promoter and Promoter Group
Sandeep Bhardwaj 3666990.0 (21.38%) Shareholding of Promoter and Promoter Group
Bhupesh Soni 3460980.0 (20.18%) Shareholding of Promoter and Promoter Group
Jaywanti Soni 504000.0 (2.94%) Shareholding of Promoter and Promoter Group
Priyanka Bharadwaj 333000.0 (1.94%) Shareholding of Promoter and Promoter Group
Praveen Mudunuri 208000.0 (1.21%) Public Shareholding
Gretex Share Broking Limited 204800.0 (1.19%) Public Shareholding
Amit Garg 182400.0 (1.06%) Public Shareholding
Anjali Dassundi 138000.0 (0.8%) Shareholding of Promoter and Promoter Group
Saroj Soni 35040.0 (0.2%) Shareholding of Promoter and Promoter Group

News

Left Arrow
Right Arrow

ZENITH DRUGS LIMITED corporate actions

  • Dividend

  • Bonus

  • Split

Dividend date Dividend amount Dividend type Record date Instrument type
[-] [-] [-] [-] [-]
Ex-Date Ex-Bonus Ratio
[-] [-] [-]
Ex-Date Old FV NEW FV Record Date
[-] [-] [-] [-]
  • Dividend

  • Bonus

  • Split

Dividend date Dividend amount Dividend type Record date Instrument type
17 Sep 2024 0.5 Final 18 Sep 2024 Equity shares
Ex-Date Ex-Bonus Ratio
[-] [-] [-]
Ex-Date Old FV NEW FV Record Date
[-] [-] [-] [-]

ZENITH DRUGS LIMITED Share Price

Zenith Drugs Ltd was originally incorporated on November 15, 2000 as a Private Limited Company in the name of 'Zenith Drugs Private Limited' issued by the Registrar of Companies, in the State of Madhya Pradesh, Gwalior. Subsequently, Company was converted into Public Limited and consequently, the name of Company was changed to Zenith Drugs Limited' pursuance to issuance of a Fresh Certificate of Incorporation on September 13, 2023 by the Registrar of Companies, Gwalior.

Zenith are a reputable pharmaceutical manufacturing and trading unit based out from Indore. With a diverse portfolio of formulations, the Company is specialized in manufacturing affordable and high quality medicines to meet the needs of patients. The Company is mainly engaged in the business of manufacturing and Trading of Medicines. It offers a wide range of formulations in various forms such as: ORS Powder; Liquid Orals; Oinments; Liquid Externals and Capsules.

The Company was established in 2000 by the visionary founders, Late Shri Ramniklal Soni, and Mr. Mukesh Jain. Initially in 2001, Company started as a modest manufacturing house for oral and external formulations. However, recognizing the importance of quality and compliance, the Company swiftly shifted to a Schedule M GMP compliant unit in 2004 where it started the production of two lines which are liquid orals and ointments. In 2007, it expanded the product line by incorporating ORS Powder manufacturing into their operations. In 2016, the Company established present manufacturing facility, which holds WHO GMP certification. In 2019, it expanded the product line by introducing liquid externals and capsules.

The Company propose Initial Public Fresh Issue upto 42,92,000 Equity Shares.

Parent organization Indian Private
NSE symbol ZENITHDRUG
Founded 2000
stock

Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Share Price of Zenith Drugs Ltd?

Answer Field

The share price of Zenith Drugs Ltd for NSE is ₹ 79.5 and for BSE is ₹ 0.00.

What is the Market Cap of Zenith Drugs Ltd?

Answer Field

The market cap of Zenith Drugs Ltd for NSE is ₹ 1,36.33 Cr. and for BSE is ₹ 0.0 Cr. as of now.

What is the 52 Week High and Low of Zenith Drugs Ltd?

Answer Field

The 52 Week High and Low of Zenith Drugs Ltd for NSE is ₹ 154.40 and ₹ 47.15 and for BSE is ₹ 0.00 and ₹ 0.00.

How to Buy Zenith Drugs Ltd share?

Answer Field

You can trade in Zenith Drugs Ltd shares with Bajaj Broking by opening a Demat Account.

What is 1 year return for Zenith Drugs Ltd?

Answer Field

The 1 year returns on the stock has been 24.02%.

What is the Current Share Price of Zenith Drugs Ltd?

Answer Field

Zenith Drugs Ltd share price is for NSE ₹ 79.5 & for BSE ₹ 0.00 as on Apr 30 2025 11:04 AM.

What is the Market Cap of Zenith Drugs Ltd Share?

Answer Field

The market cap of Zenith Drugs Ltd for NSE ₹ 1,36.33 & for BSE ₹ 0.0 as on Apr 30 2025 11:04 AM.

What is the P/E Ratio of Zenith Drugs Ltd Share?

Answer Field

As on Apr 30 2025 11:04 AM the price-to-earnings (PE) ratio for Zenith Drugs Ltd share is 14.30.

What is the PB ratio of Zenith Drugs Ltd Share?

Answer Field

As on Apr 30 2025 11:04 AM, the price-to-book (PB) ratio for Zenith Drugs Ltd share is 36.28.

How to Buy Zenith Drugs Ltd Share?

Answer Field

You can trade in Zenith Drugs Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Zenith Drugs Ltd Share on Bajaj Broking App?

Answer Field

To buy Zenith Drugs Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Zenith Drugs Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|